|Day's Range||120.40 - 123.81|
|52 Week Range||87.50 - 139.79|
|PE Ratio (TTM)||-800.33|
|Dividend & Yield||0.00 (0.00%)|
|1y Target Est||N/A|
High-margin royalty stocks could be a smart way to play a potentially pricey market.
Ligand Pharmaceuticals Incorporated (LGND) announced that it has signed a commercial license and supply agreement with Amgen Inc. granting exclusive worldwide rights to use Ligand's Captisol technology for the development of AMG 330
A banking behemoth, a social media giant, and an under-the-radar biotech company appear to be sizzling deals this July.